These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 34975739)

  • 1. Neuropathic Pain in Multiple Sclerosis and Its Animal Models: Focus on Mechanisms, Knowledge Gaps and Future Directions.
    Mirabelli E; Elkabes S
    Front Neurol; 2021; 12():793745. PubMed ID: 34975739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis-induced neuropathic pain: pharmacological management and pathophysiological insights from rodent EAE models.
    Khan N; Smith MT
    Inflammopharmacology; 2014 Feb; 22(1):1-22. PubMed ID: 24234347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment and characterization of an optimized mouse model of multiple sclerosis-induced neuropathic pain using behavioral, pharmacologic, histologic and immunohistochemical methods.
    Khan N; Woodruff TM; Smith MT
    Pharmacol Biochem Behav; 2014 Nov; 126():13-27. PubMed ID: 25223977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in a mouse model of multiple sclerosis: neuropathic pain behavior in females but not males and protection from neurological deficits during proestrus.
    Rahn EJ; Iannitti T; Donahue RR; Taylor BK
    Biol Sex Differ; 2014 Feb; 5(1):4. PubMed ID: 24581045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathological pain processing in mouse models of multiple sclerosis and spinal cord injury: contribution of plasma membrane calcium ATPase 2 (PMCA2).
    Mirabelli E; Ni L; Li L; Acioglu C; Heary RF; Elkabes S
    J Neuroinflammation; 2019 Nov; 16(1):207. PubMed ID: 31703709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropathic pain in animal models of nervous system autoimmune diseases.
    Tian DH; Perera CJ; Moalem-Taylor G
    Mediators Inflamm; 2013; 2013():298326. PubMed ID: 23737643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing Neuropathic Pain in Multiple Sclerosis: Pharmacological Interventions.
    Duffy SS; Lees JG; Perera CJ; Moalem-Taylor G
    Med Chem; 2018 Feb; 14(2):106-119. PubMed ID: 28875858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis.
    Duffy SS; Keating BA; Perera CJ; Lees JG; Tonkin RS; Makker PGS; Carrive P; Butovsky O; Moalem-Taylor G
    J Neurosci; 2019 Mar; 39(12):2326-2346. PubMed ID: 30651334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-Depth Characterization of Somatic and Orofacial Sensitive Dysfunctions and Interfering-Symptoms in a Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mouse Model.
    Démosthènes A; Sion B; Giraudet F; Moisset X; Daulhac L; Eschalier A; Bégou M
    Front Neurol; 2021; 12():789432. PubMed ID: 35111128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathic pain behaviours in a chronic-relapsing model of experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Truong JJ; Kerr BJ
    Pain; 2009 Jan; 141(1-2):156-64. PubMed ID: 19084337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peripheral sensory neuron injury contributes to neuropathic pain in experimental autoimmune encephalomyelitis.
    Wang IC; Chung CY; Liao F; Chen CC; Lee CH
    Sci Rep; 2017 Feb; 7():42304. PubMed ID: 28181561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A diminished response to formalin stimulation reveals a role for the glutamate transporters in the altered pain sensitivity of mice with experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Parmar A; Miller B; Stephan J; Tenorio G; Tran K; Leighton J; Kerr BJ
    Pain; 2010 Jun; 149(3):565-572. PubMed ID: 20399559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered excitatory-inhibitory balance within somatosensory cortex is associated with enhanced plasticity and pain sensitivity in a mouse model of multiple sclerosis.
    Potter LE; Paylor JW; Suh JS; Tenorio G; Caliaperumal J; Colbourne F; Baker G; Winship I; Kerr BJ
    J Neuroinflammation; 2016 Jun; 13(1):142. PubMed ID: 27282914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain.
    Khan N; Kuo A; Brockman DA; Cooper MA; Smith MT
    Inflammopharmacology; 2018 Feb; 26(1):77-86. PubMed ID: 28965161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of exercise interventions in animal models of multiple sclerosis.
    Parnow A; Hafedh M; Tsunoda I; Patel DI; Baker JS; Saeidi A; Bagchi S; Sengupta P; Dutta S; Łuszczki E; Stolarczyk A; Oleksy Ł; Al Kiyumi MH; Laher I; Zouhal H
    Front Med (Lausanne); 2023; 10():1143766. PubMed ID: 37089595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voluntary wheel running delays disease onset and reduces pain hypersensitivity in early experimental autoimmune encephalomyelitis (EAE).
    Benson C; Paylor JW; Tenorio G; Winship I; Baker G; Kerr BJ
    Exp Neurol; 2015 Sep; 271():279-90. PubMed ID: 26033473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNFα in MS and Its Animal Models: Implications for Chronic Pain in the Disease.
    Maguire AD; Bethea JR; Kerr BJ
    Front Neurol; 2021; 12():780876. PubMed ID: 34938263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the RNA-binding protein HuR attenuates hyperalgesia and motor disability in experimental autoimmune encephalomyelitis.
    Sanna MD; Quattrone A; Galeotti N
    Neuropharmacology; 2017 Sep; 123():116-125. PubMed ID: 28599923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in nociceptive sensitivity and object recognition in experimental autoimmune encephalomyelitis (EAE).
    Olechowski CJ; Tenorio G; Sauve Y; Kerr BJ
    Exp Neurol; 2013 Mar; 241():113-21. PubMed ID: 23291347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory cytokine gene therapy decreases sensory and motor dysfunction in experimental Multiple Sclerosis: MOG-EAE behavioral and anatomical symptom treatment with cytokine gene therapy.
    Sloane E; Ledeboer A; Seibert W; Coats B; van Strien M; Maier SF; Johnson KW; Chavez R; Watkins LR; Leinwand L; Milligan ED; Van Dam AM
    Brain Behav Immun; 2009 Jan; 23(1):92-100. PubMed ID: 18835435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.